HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Highly efficient cationic ethylphosphatidylcholine siRNA carrier for GFP suppression in modified breast cancer cells.

AbstractAIM:
Cationic ethylphosphatidylcholines (ePCs) were evaluated for the delivery of siRNA in modified breast cancer cells.
MATERIALS AND METHODS:
Dimyristoleoyl-ePC (C14), dioleoyl-ePC (C18), and dilauroyl-ePC (C12) nanoparticles were complexed with siRNA for green fluorescent protein (GFP) suppression in modified MCF-7 breast cancer cells. The kinetics of GFP suppression were followed over the course of 72 hours.
RESULTS:
C14, which has been previously found to be particularly effective in gene transfection into primary human umbilical artery endothelial cells, was also remarkably effective as siRNA carrier, with an efficacy exceeding that of Lipofectamine RNAiMAX. The C14 toxicity remained comparable to that of RNAiMAX. The efficacy of the other tested cationic ePC formulations was less than that of C14 and RNAiMAX.
CONCLUSION:
The cationic lipid C14 is a highly efficient siRNA carrier that could be used for the development of new formulations for siRNA delivery into cancer cells. A valuable advantage of the C14 formulations is the fact that they are simple, and do not require adjuvants or complex preparation procedures.
AuthorsBoris Tenchov, Yasuro Sugimoto, Rumiana Koynova, Robert W Brueggemeier, Robert J Lee
JournalAnticancer research (Anticancer Res) Vol. 32 Issue 7 Pg. 2563-6 (Jul 2012) ISSN: 1791-7530 [Electronic] Greece
PMID22753714 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Cations
  • Oleic Acids
  • Phosphatidylcholines
  • RNA, Small Interfering
  • o-ethyldioleoylphosphatidylcholinium
  • Green Fluorescent Proteins
Topics
  • Breast Neoplasms (genetics, therapy)
  • Cations (administration & dosage, chemistry)
  • Cell Line, Tumor
  • Female
  • Genetic Therapy (methods)
  • Genetic Vectors (chemistry, genetics)
  • Green Fluorescent Proteins
  • Humans
  • Nanoparticles (administration & dosage, chemistry)
  • Oleic Acids (administration & dosage, chemistry)
  • Phosphatidylcholines (administration & dosage, chemistry)
  • RNA, Small Interfering (administration & dosage, chemistry)
  • Structure-Activity Relationship
  • Transfection (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: